MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $184,451 | -24.1% | 12,712 | -0.1% | 0.06% | -36.1% |
| Q3 2022 | $243,000 | +5.2% | 12,731 | 0.0% | 0.10% | +15.5% |
| Q2 2022 | $231,000 | -27.8% | 12,731 | +0.3% | 0.08% | -3.4% |
| Q1 2022 | $320,000 | -6.4% | 12,692 | +2.5% | 0.09% | -4.4% |
| Q4 2021 | $342,000 | -14.5% | 12,385 | -0.1% | 0.09% | -22.2% |
| Q3 2021 | $400,000 | +6.7% | 12,399 | +1.2% | 0.12% | +6.4% |
| Q2 2021 | $375,000 | -19.9% | 12,247 | -20.3% | 0.11% | -31.7% |
| Q1 2021 | $468,000 | +117.7% | 15,376 | +41.4% | 0.16% | +98.8% |
| Q4 2020 | $215,000 | +51.4% | 10,876 | +0.1% | 0.08% | +22.7% |
| Q3 2020 | $142,000 | – | 10,863 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |